New melanoma drug Zelboraf may double patients’ survival Comments Off on New melanoma drug Zelboraf may double patients’ survival 395 Views People with metastatic melanoma often live six to ten months; new drug prolonged life expectancy to 16 months Read More »
Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News
